Top compounds associated with response to JUND


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 5e-06
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 5e-06
mRNA Ki8751 CTRPv2 pan-cancer AAC 0.16 5e-06
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 5e-06
mRNA quizartinib CTRPv2 pan-cancer AAC 0.17 5e-06
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 7e-06
mRNA cabozantinib CTRPv2 pan-cancer AAC 0.16 1e-05
mRNA TL-1-85 GDSC1000 pan-cancer AAC 0.13 2e-05
mRNA Imatinib CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA CAY10576 CTRPv2 pan-cancer AAC 0.17 3e-05
Download CSV